RHAGEN NELSON: Open Payments
NPI 1033769245 · OXFORD, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$168 in 7 payments from 5 companies in 2025. Trend: 2023 $92 · 2024 $220 · 2025 $168
Food & beverage: $168
| Company | Payments | Amount |
|---|---|---|
| REVANCE THERAPEUTICS, INC. | 2 | $70 |
| Janssen Pharmaceuticals, Inc | 2 | $39 |
| Otsuka America Pharmaceutical, Inc. | 1 | $22 |
| ABBVIE INC. | 1 | $20 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $17 |
Products named: DAXXIFY, SPRAVATO, REXULTI, VRAYLAR, CAPLYTA.
Industry payments across MS — which companies pay providers there.
